Natural killer cell lines in tumor immunotherapy

Area of Science:

• Immunology
• Oncology
• Biotechnology

Background:

• Natural killer (NK) cells are crucial for anti-cancer immunity.
• Cancers develop mechanisms to evade NK cell attacks or induce NK cell dysfunction.
• Current immunotherapies aim to overcome NK cell evasion and dysfunction.

Purpose of the Study:

• To review the role of NK cells in tumor immunotherapy.
• To discuss strategies for overcoming NK cell evasion in cancer.
• To list therapeutic NK cell lines in preclinical and clinical trials.

Main Methods:

• Review of current literature on NK cell-based cancer immunotherapy.
• Analysis of strategies including autologous NK cell activation, allogeneic NK cell expansion, and use of NK cell lines.
• Examination of genetic modification techniques for enhancing NK cell function (cytokine expression, chimeric antigen receptors).

Main Results:

• Stable allogeneic NK cell lines offer practical advantages for quality control and large-scale production.
• Genetic modification of NK cell lines can improve specificity and cytotoxicity.
• Various therapeutic NK cell lines are progressing through preclinical and clinical trials for different tumor types.

Conclusions:

• NK cell-based therapies hold significant promise for cancer treatment.
• Stable, genetically modified NK cell lines represent a practical and potentially potent approach to cancer immunotherapy.
• Further research and clinical trials are essential to optimize NK cell therapy efficacy.